C-30 analogues of betulinic acid as potent cytotoxic agents: design, synthesis, biological evaluation and in-silico studies

References

• Bennett, D. T., Deng, X.-S., Jessica, A. Y., Bell, M. T., Mauchley, D. C., Meng, X., Reece, T. B., Fullerton, D. A., & Weyant, M. J. (2014). Cancer stem cell phenotype is supported by secretory phospholipase A2 in human lung cancer cells. The Annals of Thoracic Surgery, 98(2), 439–446. https://doi.org/10.1016/j.athoracsur.2014.04.044
   PubMed Web of Science ®Google Scholar
• Borkova, L., Gurska, S., Dzubak, P., Burianova, R., Hajduch, M., Sarek, J., Popa, I., & Urban, M. (2016). Lupane and 18α-oleanane derivatives substituted in the position 2, their cytotoxicity and influence on cancer cells. European Journal of Medicinal Chemistry, 121, 120–131. https://doi.org/10.1016/j.ejmech.2016.05.029
   PubMed Web of Science ®Google Scholar
• Cai, Y., Zheng, Y., Gu, J., Wang, S., Wang, N., Yang, B., Zhang, F., Wang, D., Fu, W., & Wang, Z. (2018). Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78. Cell Death & Disease, 9(6), 636. https://doi.org/10.1038/s41419-018-0669-8
   PubMed Web of Science ®Google Scholar
• Chintharlapalli, S., Papineni, S., Lei, P., Pathi, S., & Safe, S. (2011). Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer, 11(1), 371. https://doi.org/10.1186/1471-2407-11-371
   PubMedGoogle Scholar
• Cui, H.-W., He, Y., Wang, J., Gao, W., Liu, T., Qin, M., Wang, X., Gao, C., Wang, Y., Liu, M.-Y., Yi, Z., & Qiu, W.-W. (2015). Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents. European Journal of Medicinal Chemistry, 95, 240–248. https://doi.org/10.1016/j.ejmech.2015.03.048
   PubMed Web of Science ®Google Scholar
• Dangroo, N. A., Singh, J., Rath, S. K., Gupta, N., Qayum, A., Singh, S., & Sangwan, P. L. J. S. (2017). A convergent synthesis of novel alkyne-azide cycloaddition congeners of betulinic acid as potent cytotoxic agent. Steroids, 123, 1–12. https://doi.org/10.1016/j.steroids.2017.04.002
   PubMed Web of Science ®Google Scholar
• Dwibedi, V., Mishra, S. S., George, N., Joshi, M., Kaur, G., Gupta, M., & Rath, S. K. (2023). Purification of ursolic acid and β-sitosterol from endophytic Alternaria alternata for their alpha-amylase inhibitory activity. Journal of Biomolecular Structure & Dynamics, 1–12. https://doi.org/10.1080/07391102.2023.2236717
   PubMed Web of Science ®Google Scholar
• Gupta, A., Kumar, B. S., & Negi, A. S. (2013). Current status on development of steroids as anticancer agents. The Journal of Steroid Biochemistry and Molecular Biology, 137, 242–270. https://doi.org/10.1016/j.jsbmb.2013.05.011
   PubMed Web of Science ®Google Scholar
• Gupta, N., Rath, S. K., Singh, J., Qayum, A., Singh, S., & Sangwan, P. L. (2017). Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents. European Journal of Medicinal Chemistry, 135, 517–530. https://doi.org/10.1016/j.ejmech.2017.04.062
   PubMed Web of Science ®Google Scholar
• Hill, R. A., & Connolly, J. D. (2017). Triterpenoids. Natural Product Reports, 34(1), 90–122. https://doi.org/10.1039/c6np00094k
   PubMed Web of Science ®Google Scholar
• Hsu, T.-I., Wang, M.-C., Chen, S.-Y., Huang, S.-T., Yeh, Y.-M., Su, W.-C., Chang, W.-C., & Hung, J.-J. (2012). Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth. Molecular Pharmacology, 82(6), 1115–1128. https://doi.org/10.1124/mol.112.078485
   PubMed Web of Science ®Google Scholar
• Khan, I., Guru, S. K., Rath, S. K., Chinthakindi, P. K., Singh, B., Koul, S., Bhushan, S., Sangwan, P. L. (2016). A novel triazole derivative of betulinic acid induces extrinsic and intrinsic apoptosis in human leukemia HL-60 cells. European Journal of Medicinal Chemistry, 108, 104–116. https://doi.org/10.1016/j.ejmech.2015.11.018
   PubMed Web of Science ®Google Scholar
• Khan, M. F., Nahar, N., Rashid, R. B., Chowdhury, A., & Rashid, M. A. (2018). Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2). BMC Complementary and Alternative Medicine, 18(1), 48. https://doi.org/10.1186/s12906-018-2116-x
   PubMedGoogle Scholar
• Kim, J. Y., Koo, H.-M., & Kim, D. S. (2001). Development of C-20 modified betulinic acid derivatives as antitumor agents. Bioorganic & Medicinal Chemistry Letters, 11(17), 2405–2408. https://doi.org/10.1016/s0960-894x(01)00460-7
   PubMed Web of Science ®Google Scholar
• Lan, P., Wang, J., Zhang, D.-M., Shu, C., Cao, H.-H., Sun, P.-H., Wu, X.-M., Ye, W.-C., & Chen, W.-M. (2011). Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives. European Journal of Medicinal Chemistry, 46(6), 2490–2502. https://doi.org/10.1016/j.ejmech.2011.03.038
   PubMed Web of Science ®Google Scholar
• Li, L., Du, Y., Kong, X., Li, Z., Jia, Z., Cui, J., Gao, J., Wang, G., & Xie, K. (2013). Lamin B1 is a novel therapeutic target of betulinic acid in pancreatic cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 19(17), 4651–4661. https://doi.org/10.1158/1078-0432.CCR-12-3630
   PubMed Web of Science ®Google Scholar
• Majeed, R., Hamid, A., Sangwan, P. L., Chinthakindi, P. K., Koul, S., Rayees, S., Singh, G., Mondhe, D. M., Mintoo, M. J., Singh, S. K., Rath, S. K., & Saxena, A. K. (2014). Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin. Cell Death & Disease, 5(10), e1459-e1459. https://doi.org/10.1038/cddis.2014.387
   Google Scholar
• Mandal, S. K., Das, A., Bose, A., Dwibedi, V., Ganguly, P., Sarkar, S., Prakash, R., Dey, B. K., Mandal, S., & Rath, S. K. (2023). Hetero cyclic compounds in the treatment of triple-negative breast cancer. Current Cancer Therapy Reviews, 19(3), 237–259. https://doi.org/10.2174/1573394719666221230111838
   Web of Science ®Google Scholar
• Pokorny, J., Krajcovicova, S., Hajduch, M., Holoubek, M., Gurska, S., Dzubak, P., Volna, T., Popa, I., & Urban, M. (2018). Triterpenic azines, a new class of compounds with selective cytotoxicity to leukemia cells CCRF-CEM. Future Medicinal Chemistry, 10(5), 483–491. https://doi.org/10.4155/fmc-2017-0171
   PubMed Web of Science ®Google Scholar
• Rello, S., Stockert, J. C., Moreno, V., Gámez, A., Pacheco, M., Juarranz, A., Cañete, M., & Villanueva, A. (2005). Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis: An International Journal on Programmed Cell Death, 10(1), 201–208. https://doi.org/10.1007/s10495-005-6075-6
   PubMed Web of Science ®Google Scholar
• Rodriguez-Rodriguez, R., & Ruiz-Gutiérrez, V. (2010). In olives and olive oil in health and disease prevention. Elsevier, pp. 813–820.
   Google Scholar
• Shankar, E., Zhang, A., Franco, D., & Gupta, S. (2017). Betulinic acid-mediated apoptosis in human prostate cancer cells involves p53 and nuclear factor-kappa B (NF-κB) pathways. Molecules (Basel, Switzerland), 22(2), 22–264. https://doi.org/10.3390/molecules22020264
   Web of Science ®Google Scholar
• Shi, W., Tang, N., & Yan, W.-D. (2015). Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry. Journal of Asian Natural Products Research, 17(2), 159–169. https://doi.org/10.1080/10286020.2014.979164
   PubMed Web of Science ®Google Scholar
• Twilley, D., & Lall, N. (2018). Natural products and drug discovery. Elsevier, pp. 139–178.
   Google Scholar
• Waechter, F., da Silva, G. N., Willig, J. B., de Oliveira, C. B., Vieira, B. D., Trivella, D. B., Zimmer, A. R., Buffon, A., Pilger, D. A., & Gnoatto, S. C. (2017). Design, synthesis and biological evaluation of betulinic acid derivatives as new antitumor agents for leukemia. Anti-Cancer Agents in Medicinal Chemistry, 17(13), 1777–1785. https://doi.org/10.2174/1871521409666170412143638
   PubMed Web of Science ®Google Scholar
• Wang, L., Wesemann, S., Krenn, L., Ladurner, A., Heiss, E. H., Dirsch, V. M., & Atanasov, A. G. (2017). Erythrodiol, an olive oil constituent, increases the half-life of ABCA1 and enhances cholesterol efflux from THP-1-derived macrophages. Frontiers in Pharmacology, 8, 375. https://doi.org/10.3389/fphar.2017.00375
   PubMed Web of Science ®Google Scholar
• Xu, C., Wang, B., Pu, Y., Tao, J., & Zhang, T. (2018). Techniques for the analysis of pentacyclic triterpenoids in medicinal plants. Journal of Separation Science, 41(1), 6–19. https://doi.org/10.1002/jssc.201700201
   PubMed Web of Science ®Google Scholar